Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 1 year.
Xeris Biopharma Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Grant or award | +24,193 | — | — |
| Mar 30, 2026 | Xeris Biopharma Holdings Inc. | Open-market sale | −10,834 | $5.54 | $60,020 |
| Mar 28, 2025 | Xeris Biopharma Holdings Inc. | Grant or award | +100,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.